A recent breakthrough in biosensor technology has paved the way for a novel approach to measuring cortisol levels, a key indicator of stress, with high accuracy. Developed by Andy Yeh, an assistant professor of biomolecular engineering at the University of California, Santa Cruz, this protein-based biosensor offers the potential for point-of-care testing, making stress monitoring more accessible than ever before. Cortisol, crucial for regulating various body functions, can impact health significantly when imbalanced.
Traditional methods of cortisol measurement often involve visits to healthcare facilities. Yeh’s innovative biosensor, which binds to cortisol molecules in blood or urine and emits light signals in response, has been proven to detect cortisol levels effectively across the range critical for human health. By integrating this biosensor with smartphone cameras, cortisol levels can now be monitored conveniently at home or in clinics, combining accuracy with affordability and eliminating the need for costly laboratory equipment.
Yeh’s expertise in artificial protein engineering, utilizing AI-based computational design, led to the creation of a biosensor that demonstrates exceptional sensitivity and dynamic range in detecting cortisol levels. The biosensor functions by bringing two engineered proteins closer upon cortisol binding, resulting in light emission proportional to cortisol concentration. This computational design approach represents a significant advancement in biosensor technology, enabling more precise and sensitive hormone monitoring compared to current methods.
The biosensor’s application involves a simple “mix and read” format, akin to rapid Covid-19 tests, requiring only a small sample of blood or urine mixed with a biosensor-containing solution. Subsequently, a smartphone camera and app can capture and interpret the emitted light, providing direct measurements of cortisol levels. Yeh emphasizes the field compatibility of this approach, offering a user-friendly method for stress monitoring that surpasses traditional tests in sensitivity and dynamic range, catering to various cortisol levels.
Yeh envisions broader applications for this technology beyond stress monitoring, potentially extending to drug development and diagnostics for conditions related to cortisol imbalances. The biosensor’s remarkable sensitivity and wide dynamic range set it apart from conventional methods, offering quantitative results for both normal and elevated cortisol levels. Supported by prominent funding sources, including the National Institutes of Health and the Chan Zuckerberg Initiative, this innovative biosensor represents a significant step towards personalized and accessible stress monitoring tools.
In conclusion, the integration of a protein-based biosensor with smartphone cameras presents a groundbreaking advancement in stress monitoring technology, offering a user-friendly and cost-effective solution for measuring cortisol levels accurately. Yeh’s pioneering work in artificial protein engineering has led to the development of a biosensor with unparalleled sensitivity and dynamic range, setting a new standard for hormone monitoring. With potential applications in various healthcare settings, this biosensor holds promise for revolutionizing the understanding and treatment of health conditions associated with cortisol imbalances.
Key Takeaways:
– The protein-based biosensor developed by Andy Yeh enables accurate measurement of cortisol levels, essential for stress monitoring.
– Integrating the biosensor with smartphone cameras allows for convenient, at-home cortisol testing with high sensitivity and affordability.
– Yeh’s computational design approach in artificial protein engineering has led to a biosensor with exceptional sensitivity and dynamic range, surpassing traditional methods.
– The biosensor’s potential applications extend beyond stress monitoring to drug development and diagnostics for conditions related to cortisol imbalances.
Tags: protein engineering, biosensors, biotech
Read more on scitechdaily.com